Jazz Pharmaceuticals Announces First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. ISRG
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Jazz Pharmaceuticals Announces First Quarter 2018 Financial Results

Jazz Pharmaceuticals (JAZZ) PT Raised to $201 at BMO Capital

May 9, 2018 6:45 AM EDT

BMO Capital raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $201.00 (from $199.00) while maintaining an Outperform rating.

Analyst Gary Nachman commented, "JAZZ reported 1Q revenue of $445mm vs. BMO/consensus $433mm/$434mm and adj. EPS of $2.98 vs. BMO/consensus $2.74/$2.77. The... More

Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 21c

May 8, 2018 4:34 PM EDT

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q1 EPS of $2.98, $0.21 better than the analyst estimate of $2.77. Revenue for the quarter came in at $444.61 million versus the consensus estimate of $434.87 million.

"The first quarter was highlighted by strong revenue growth, cash flow generation and execution across... More